Describe acute respiratory distress syndrome with its causes, pathogenesis and morphology.
Definition
Acute respiratory distress syndrome (ARDS) is acute, diffuse, inflammatory lung injury causing increased alveolar-capillary permeability, non-cardiogenic pulmonary oedema and severe hypoxaemia refractory to oxygen. Its histological counterpart is diffuse alveolar damage.
Berlin definition
- Acute onset within 1 week of a known insult
- Bilateral opacities on chest imaging, not fully explained by effusion, collapse or nodules
- Not fully explained by cardiac failure or fluid overload — hence the term non-cardiogenic
- Impaired oxygenation — PaO2/FiO2 ratio 300 or less (mild 200–300, moderate 100–200, severe under 100)
Causes
| Direct lung injury | Indirect (systemic) injury |
|---|---|
| Pneumonia | Sepsis — the commonest cause overall |
| Aspiration of gastric contents | Severe trauma with shock; multiple fractures |
| Inhalation of smoke or toxic gases | Acute pancreatitis |
| Near-drowning | Massive transfusion; TRALI |
| Pulmonary contusion | Burns; DIC; drug overdose; fat embolism |
| Oxygen toxicity; radiation | Cardiopulmonary bypass; eclampsia |
Pathogenesis
The insult activates alveolar macrophages → Release of IL-1, IL-8 and TNF → neutrophils are recruited and sequestered in the pulmonary capillaries → They release proteases, reactive oxygen species and leukotrienes → Damage to both the endothelium and the alveolar epithelium → Increased permeability → protein-rich exudate floods the alveoli → Loss of type II pneumocytes → surfactant deficiency → widespread collapse → hyaline membranes form from fibrin and necrotic cell debris → Severe ventilation–perfusion mismatch and shunting → refractory hypoxaemia
Morphology — Diffuse Alveolar Damage
| Phase | Timing | Features |
|---|---|---|
| Exudative | First week | Heavy, red, boggy, airless lungs; congestion, interstitial and intra-alveolar oedema, fibrin, and the characteristic hyaline membranes lining the alveolar ducts; necrosis of type I pneumocytes |
| Proliferative (organising) | 1–3 weeks | Type II pneumocyte hyperplasia attempting repair; fibroblast proliferation; organisation of the exudate |
| Fibrotic | After 3–4 weeks | Interstitial fibrosis; honeycombing in survivors |
CLINICAL PEARL
ARDS and cardiogenic pulmonary oedema look alike on the radiograph and are treated in opposite ways. ARDS is a permeability problem: the pulmonary capillary wedge pressure is normal, the fluid is protein-rich, and diuresis alone does not fix it. Cardiogenic oedema is a pressure problem: the wedge pressure is raised, the fluid protein-poor, and diuretics work. Getting this wrong is dangerous in both directions.
Applied Aspects
- Treat the underlying cause — nothing else alters the outcome; source control in sepsis is the priority
- Lung-protective ventilation saves lives — low tidal volume (about 6 mL/kg predicted body weight) and limited plateau pressure, accepting some hypercapnia. Large tidal volumes cause ventilator-induced lung injury by overdistending the few remaining normal alveoli
- PEEP recruits collapsed alveoli and improves oxygenation
- Prone positioning improves survival in severe ARDS by improving ventilation–perfusion matching
- Conservative fluid management once shock is corrected shortens ventilation
- Mortality remains about 30 to 40%, usually from multi-organ failure rather than from hypoxaemia; survivors may have long-term impairment of lung function and quality of life
All questions in Respiratory Pathology
- Q1Define chronic obstructive pulmonary disease. Describe chronic bronchitis and emphysema with their types, pathogenesis and morphology. ★
- Q2Classify pneumonia. Describe the stages of lobar pneumonia and differentiate it from bronchopneumonia. ★
- Q3Define pulmonary hypertension and cor pulmonale. Classify pulmonary hypertension and describe its pathogenesis and morphology. ★
- Q4Classify carcinoma of the lung. Describe the morphology, local effects and spread of the major types. ★
- Q5Classify interstitial lung disease. Describe the pneumoconioses and idiopathic pulmonary fibrosis. ★
- SN1Describe bronchial asthma with its types, pathogenesis and morphology. ★
- SN2Define bronchiectasis. Describe its causes, pathogenesis and complications. ★
- SN3Describe acute respiratory distress syndrome with its causes, pathogenesis and morphology. ★
- SN4Describe lung abscess with its causes, morphology and complications. ★
- SN5Classify pleural effusion. Describe malignant mesothelioma and add a note on pneumothorax. ★
- SN6Define atelectasis. Classify it and describe its causes and consequences. ★
- SN7Describe sarcoidosis with its morphology, clinical features and diagnosis.